SOMERVILLE, N.J. -- Johnson & Johnson Wound Management today announced PROMOGRAN PRISMA* Matrix as the latest addition to its family of chronic wound dressings. Developed to provide protection and growth in a changing wound environment, PRISMA Matrix absorbs destructive components of wound exudate while promoting healthy tissue healing.
The unique combination of collagen, oxidized regenerated cellulose (ORC)
and silver-ORC+ delivers a balanced combination of protection and growth for a
variety of wound types and conditions at any exudate level. PRISMA Matrix
removes destructive elements and components in wound fluid, kills clinically
relevant bacteria in the dressing to help maintain bacterial balance and
reduces bacterial growth, which may reduce the risk of infection. The dressing
also promotes healthy tissue growth while delivering silver to the wound. The
collagen provides a biodegradable matrix for cellular invasion and capillary
growth while creating an environment that promotes the formation of
granulation tissue, epithelialization and optimal wound healing.
"With PRISMA Matrix, Johnson & Johnson Wound Management continues its
pioneering role as a wound care industry leader," states William Li, MD,
president of the Angiogenesis Foundation in Cambridge, Mass. "This single
product is an integrated technology that addresses multiple factors causing
impaired healing. PRISMA Matrix can be used as part of the standard approach
to restoring proper balance in the wound bed to promote successful healing."
PRISMA Matrix is intended for the management of exuding wounds. Under the
supervision of a healthcare professional, PRISMA Matrix may be used for the
management of diabetic, venous and pressure ulcers, ulcers caused by mixed
vascular etiologies, full -- and partial-thickness wounds, donor sites and
other bleeding surface wounds, abrasions, traumatic wounds healing by
secondary intention and dehisced surgical wounds. PRISMA Matrix may be used
under compression therapy with healthcare professional supervision.
PRISMA Matrix is not indicated for third-degree burns or patients with
known sensitivity to silver, ORC or collagen. PRISMA Matrix may be used when
visible signs of infection are present in the wound area only when proper
medical treatment addresses the underlying cause. PRISMA Matrix is not
intended to be a substitute for appropriate treatment of infection.
* Trademark
+ Silver-ORC contains 0.25 percent ionically-bound silver.
Source: Johnson & Johnson Wound Management
Infection Prevention Protocols in Facelift Surgery: Expert Insights
November 15th 2023Unlock the secrets to infection prevention in facelift surgery as renowned surgeons Dr. Konstantin Vasyukevic and Dr. Peter Lee share their expert insights and meticulous protocols in this informative interview.